GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, PTGS2, SMAD3, SRC, TEK, TYR |
9.91046 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
8.84585 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALPL, APEX1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, PTGS2, SMAD3, SRC, TEK, TYR |
8.59875 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, GSK3B, HSD17B2, IDO1, IGF1R, INSR, PTGS2, SRC, TEK, TYR |
8.54455 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
8.31584 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GSK3B, HSPA1A, IDO1, IGF1R, KDR, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
8.19075 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, PIM1, SRC, TEK |
7.99372 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FLT3, PTGS2, SRC, TEK, TYR |
7.99372 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9, DHFR |
7.99372 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP4, FLT3, GLO1, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
7.94557 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK |
7.87346 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.43934 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DHFR, EGFR, ESR1, F10, FABP4, FLT3, GPR35, GSK3B, HSD17B2, HSPA1A, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK, XDH |
7.37573 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP4, FLT3, GLO1, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
7.37449 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, GLO1, HSPA1A, IDO1, PIM1, PTGS2, TYR, XDH |
7.37449 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK |
7.35517 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FLT3, HSD17B2, IDO1, PTGS2, SRC, TYR |
7.2212 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FLT3, GSK3B, IGF1R, INSR, PTGS2, SMAD3, SRC, TEK |
7.21493 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, GSK3B, HSPA1A, IDO1, IGF1R, KDR, PIM1, PTGS2, SMAD3, SRC, TEK |
7.20526 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
7.18084 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, GSK3B, HSPA1A, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK, XDH |
7.00329 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, GSK3B, HSPA1A, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK, XDH |
6.99413 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, GSK3B, HSD17B2, IDO1, PTGS2, TYR, XDH |
6.96974 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, SMAD3, SRC, TEK, TYR |
6.92293 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FLT3, INSR, PTGS2, SRC, TEK |
6.90569 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
6.60407 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APEX1, AURKB, AXL, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, GLO1, GSK3B, HSD17B2, INSR, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, TYR |
6.50368 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, FLT3, HSPA1A, IDO1, IGF1R, INSR, KDR, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
6.32611 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTGS2, SRC, TEK, XDH |
6.31714 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
6.08911 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
6.06184 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FLT3, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
6.05798 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
6.04628 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
6.01556 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
6.0015 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APEX1, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, F10, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, NUAK1, PTGS2, SMAD3, SRC, TEK, TOP2A, TYR |
5.96654 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.96654 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GSK3B, HSD17B2, INSR, KDR, PIM1, PTGS2, SMAD3, SRC, TEK, TYR |
5.93316 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, CSNK2A1, DHFR, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SRC, TEK, XDH |
5.82318 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, PTGS2, SRC |
5.81003 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
5.78358 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
5.77982 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AXL, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, PTGS2, SRC, TEK, XDH |
5.70197 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
5.69916 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTGS2, SMAD3, SRC, TOP2A |
5.66681 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, CYP19A1, DHFR, DUSP3, EGFR, ESR1, FABP4, GSK3B, HSPA1A, IDO1, IGF1R, MET, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
5.66068 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
5.57903 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, PTGS2, SMAD3, SRC |
5.5754 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, CSNK2A1, DHFR, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SRC, TEK, XDH |
5.54428 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
5.54428 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AXL, CSNK2A1, CYP1B1, EGFR, F10, FLT3, GPR35, GSK3B, HSPA1A, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK, XDH |
5.46265 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
5.41106 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
5.39735 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
5.36148 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, FABP4, HSD17B2, MET, PTGS2 |
5.34366 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, INSR, KDR, PTGS2, SMAD3, SRC |
5.29631 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AXL, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IDO1, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK, XDH |
5.13424 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, APEX1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
5.02913 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
4.77093 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, F10, FLT3, GSK3B, IGF1R, INSR, KDR, MET, SRC, TEK, TOP2A |
4.64412 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, SRC, TEK, XDH |
4.51735 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP4, FLT3, GLO1, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.51578 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
4.39979 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DHFR, EGFR, HSPA1A, IDO1 |
4.3385 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, SRC, TEK, TYR |
4.33811 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, AURKB, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IGF1R, INSR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
4.33811 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.33811 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.33811 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, SRC, TEK |
4.31939 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
4.26606 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
4.21387 |
[BP] GO:0030335 |
positive regulation of cell migration
|
EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
4.12315 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
4.1229 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HSD17B2 |
4.06883 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, DHFR, EGFR, INSR, PTGS2, SMAD3, XDH |
4.04968 |
[BP] GO:2000147 |
positive regulation of cell motility
|
EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
4.01917 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, PTGS2, SRC |
4.00443 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.97735 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, SRC |
3.97735 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, AXL, CA12, CA2, CA7, EGFR, ESR1, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC |
3.96932 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
3.93532 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, DHFR, EGFR, KDR, PTGS2, SRC |
3.8951 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP4, FLT3, GLO1, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
3.89277 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.88561 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.88561 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, DHFR, DUSP3, EGFR, ESR1, F10, FLT3, GLO1, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
3.85476 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.8458 |
[BP] GO:0040017 |
positive regulation of locomotion
|
EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
3.82083 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DHFR, EGFR, FLT3, GSK3B, IGF1R, INSR, PTGS2, SRC, TEK, TYR |
3.77108 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, PTGS2, SRC |
3.72633 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, SRC |
3.72484 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, PTGS2, SMAD3, TEK |
3.70432 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, ALOX5, ALPL, AXL, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, FABP4, HSD17B2, IDO1, IGF1R, INSR, MET, PIM1, PTGS2, SMAD3, SRC, TEK, TYR |
3.60366 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, PTGS2, SMAD3, SRC, XDH |
3.5956 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, PTGS2, SMAD3, SRC, XDH |
3.58204 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
3.54595 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DHFR, EGFR, FLT3, GSK3B, IGF1R, INSR, PTGS2, SRC, TEK, TYR |
3.45828 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.42619 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, EGFR, ESR1, FLT3, GSK3B, IGF1R, INSR, PTGS2, SMAD3, SRC |
3.42619 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.42619 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.42619 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, GSK3B, IGF1R, MET, PIM1, PTGS2, SRC |
3.38063 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
3.30536 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPR35, GSK3B, HSPA1A, IDO1, INSR, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
3.29232 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, GLO1, IDO1, PIM1, PTGS2, TYR |
3.28645 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, PTGS2, SRC |
3.16454 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
3.13212 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
3.13212 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, XDH |
3.12917 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, GSK3B, IGF1R, INSR, PTGS2, SRC, TEK |
3.12366 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PTGS2, SRC |
3.11599 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.08434 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, GSK3B, HSPA1A, IDO1, NUAK1, PTGS2, SMAD3, SRC, TEK, TOP2A |
3.08434 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, ESR1, GSK3B, IGF1R, INSR, PTGS2, SRC |
3.06355 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, GLO1, IDO1, PTGS2 |
3.04831 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, EGFR, INSR, PTGS2, SMAD3 |
3.0364 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
3.00224 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, TEK |
2.99856 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.99729 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, SRC |
2.9441 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, KDR, MET, PTGS2, SMAD3, TEK |
2.9441 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
2.9441 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.9441 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.9441 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.9441 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.9441 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, SRC |
2.9441 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, CYP19A1, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, PTGS2, SMAD3, SRC, TEK, XDH |
2.94162 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, IDO1, PTGS2, SMAD3, SRC, TEK |
2.93474 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, GLO1, IDO1, PIM1, PTGS2, TYR |
2.93225 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, SRC, TEK |
2.91285 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DHFR, EGFR, SMAD3 |
2.90276 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HSD17B2 |
2.90276 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
DHFR, DUSP3, EGFR, GSK3B, HSPA1A, IGF1R, MET, NUAK1, PTGS2, XDH |
2.89131 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, AXL, CA2, CYP19A1, EGFR, GSK3B, INSR, PTGS2, SMAD3, SRC |
2.88527 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.88527 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, FABP4, MET, PTGS2 |
2.88527 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, GLO1, IDO1, PIM1, PTGS2, TYR |
2.88304 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
2.882 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, FABP4, IDO1, KDR, MET, PTGS2, SMAD3 |
2.86627 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, AURKB, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TOP2A |
2.85435 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.84967 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.84462 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, EGFR, GSK3B, IGF1R, INSR, PTGS2, SRC |
2.84397 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.83483 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, ESR1, GSK3B, SRC, TOP2A |
2.8318 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, AURKB, DHFR, EGFR, ESR1, ESR2, FLT3, GSK3B, HSPA1A, INSR, MET, SMAD3, SRC, TEK, XDH |
2.81196 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, AURKB, CA9, CSNK2A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
2.80185 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, CYP1A1, CYP1B1, KDR, SRC |
2.80185 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SMAD3, SRC, TOP2A |
2.80072 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.79591 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, IDO1, INSR, PTGS2, SRC, TOP2A |
2.79249 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.79249 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.79249 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, EGFR, HSPA1A, PTGS2, SMAD3, SRC, TEK, TYR |
2.76108 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
2.74315 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
2.74315 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.70883 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.70883 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
2.70674 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
2.70674 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.67619 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, EGFR, PTGS2 |
2.66076 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.64915 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.64915 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, EGFR, GSK3B, IGF1R, INSR, PTGS2, SRC |
2.64698 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, GSK3B, IGF1R, INSR, SRC |
2.62763 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2 |
2.62311 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.61581 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP4, FLT3, GLO1, GPR35, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.61581 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, PTGS2, SRC, TEK |
2.61202 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, SRC, TEK, XDH |
2.60813 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.6028 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP4, GSK3B, HSPA1A, IDO1, SRC, XDH |
2.6028 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, PIM1, PTGS2, TEK |
2.58257 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, EGFR, HSD17B2, KDR, PTGS2, SRC |
2.55151 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.54879 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, SRC |
2.54682 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, CA2, EGFR, FLT3, PTGS2, SRC |
2.52815 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AURKB, CSNK2A1, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
2.51929 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.49812 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP2A6, HSPA1A, IDO1, XDH |
2.49812 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
2.47329 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, APEX1, CSNK2A1, EGFR, ESRRB, GSK3B, HSPA1A, INSR, KDR, MET, SMAD3 |
2.47011 |
[BP] GO:0031099 |
regeneration
|
AXL, CSNK2A1, DHFR, EGFR, FLT3 |
2.46729 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
2.46729 |
[BP] GO:0006091 |
generation of precursor metabolites and energy
|
AKR1B1, AOX1, CYP19A1, CYP1A2, GSK3B, IDO1, XDH |
2.45858 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.45858 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.45858 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.45858 |
[BP] GO:0042180 |
None
|
AKR1B1, CYP19A1, GLO1, IDO1 |
2.44841 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, GSK3B, IDO1, INSR, KDR, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
2.44605 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, SRC |
2.43512 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.41221 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.41221 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.41221 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, GSK3B, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK |
2.39893 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, EGFR, KDR, PTGS2, SRC |
2.39047 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, EGFR, ESR1, FABP4, GPR35, INSR, MET, SMAD3 |
2.37511 |
[BP] GO:0005979 |
None
|
ESRRB, GSK3B, INSR |
2.37511 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.37511 |
[BP] GO:0010962 |
None
|
ESRRB, GSK3B, INSR |
2.37511 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
2.3751 |
[BP] GO:0048729 |
tissue morphogenesis
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.33833 |
[BP] GO:0048732 |
gland development
|
CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.33634 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ESR1, GSK3B, HSPA1A, KDR, MET, SMAD3, SRC, TEK |
2.33634 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, APEX1, AXL, CA2, CA9, CYP1B1, DHFR, EGFR, GSK3B, HSPA1A, NUAK1, PTGS2, SRC, TOP2A |
2.33634 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, PTGS2 |
2.33557 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
2.33415 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
2.326 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.32275 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, CA2, CYP1B1, EGFR, ESRRB, HSPA1A, IDO1, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK |
2.32275 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP4, GSK3B, HSPA1A, IDO1, SRC, XDH |
2.31816 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
2.30356 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, IGF1R, KDR, MET, PTGS2, SMAD3, SRC, XDH |
2.28185 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP4, GSK3B, HSPA1A, IDO1, XDH |
2.27074 |
[BP] GO:0050793 |
regulation of developmental process
|
AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GSK3B, IDO1, INSR, KDR, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
2.27074 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
2.26661 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.26661 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, EGFR, FLT3, PTGS2, SRC |
2.26661 |
[BP] GO:0003018 |
None
|
ADORA1, EGFR, PTGS2, SRC, TEK |
2.26661 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CYP1A1, DUSP3, EGFR, INSR, SRC |
2.25394 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
AURKB, AXL, ESR1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.24334 |
[BP] GO:0070873 |
None
|
ESRRB, GSK3B, INSR |
2.23304 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.23304 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.23304 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, EGFR, FLT3, INSR, KDR, SRC, TEK, XDH |
2.23121 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7 |
2.23121 |
[BP] GO:1903426 |
None
|
EGFR, INSR, PTGS2, SMAD3 |
2.23121 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.23121 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, PTGS2, SMAD3, SRC, TEK |
2.22499 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, PTGS2, SMAD3, SRC, XDH |
2.21211 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.2023 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, ESR1, HSPA1A, IGF1R, MET, PTGS2, SRC, XDH |
2.2023 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APEX1, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
2.19368 |
[BP] GO:0030155 |
regulation of cell adhesion
|
CYP1B1, DUSP3, GSK3B, IDO1, KDR, NUAK1, SMAD3, SRC, TEK |
2.19222 |
[BP] GO:0010595 |
positive regulation of endothelial cell migration
|
KDR, MET, PTGS2, TEK |
2.18172 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.16787 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, PTGS2, SMAD3, SRC, TEK |
2.16707 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, DUSP3, EGFR, FABP4, FLT3, GSK3B, IGF1R, INSR, SRC, TEK |
2.16707 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, SRC |
2.14967 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, CYP19A1, ESR1, HSD17B2, INSR, SRC |
2.14405 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.1384 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, SRC |
2.1384 |
[BP] GO:0032885 |
regulation of polysaccharide biosynthetic process
|
ESRRB, GSK3B, INSR |
2.1384 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, CSNK2A1, EGFR, ESR1, FLT3, GSK3B, HSPA1A, INSR, KDR, PTGS2, SMAD3, SRC, TEK, XDH |
2.13289 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.11342 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, AURKB, DHFR, EGFR, ESR1, FLT3, GSK3B, HSPA1A, INSR, SMAD3, SRC, TEK, XDH |
2.11024 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, EGFR, FABP4, PTGS2 |
2.10437 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
2.10124 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, AXL, CA2, CA7, CYP19A1, EGFR, GPR35, GSK3B, HSPA1A, INSR, PTGS2, SMAD3, SRC |
2.08279 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
2.07541 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, SRC |
2.04024 |
[BP] GO:0045124 |
None
|
CA2, EGFR, SRC |
2.04024 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, INSR, SRC |
2.00831 |
[BP] GO:0034405 |
response to fluid shear stress
|
CA2, PTGS2, SRC |
2.00831 |
[BP] GO:0032881 |
regulation of polysaccharide metabolic process
|
ESRRB, GSK3B, INSR |
2.00831 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, EGFR, ESR1, F10, FLT3, GLO1, GPR35, GSK3B, IGF1R, INSR, KDR, MET, PIM1, SMAD3, SRC, TEK |
2.8704 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.84462 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX5, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, F10, FLT3, GLO1, GPR35, GSK3B, HSD17B2, IGF1R, INSR, KDR, MET, PIM1, PTGS2, SMAD3, SRC, TEK, TYR |
2.49241 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, AXL, CA2, CA4, CA9, DUSP3, EGFR, F10, FLT3, GPR35, IGF1R, INSR, KDR, MET, PTGS2, SRC, TEK |
2.29957 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADORA1, CA2, CA4, CA9, EGFR, INSR, MET, PTGS2, SRC, TEK |
2.26874 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP4, FLT3, GLO1, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
13.162 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, DUSP3, EGFR, F10, FLT3, GLO1, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SRC, TEK, TOP2A, TYR, XDH |
11.8261 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, GLO1, PIM1, SMAD3, TYR, XDH |
10.8111 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.5133 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DHFR, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
7.99372 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.99372 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.43934 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.35517 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, IDO1, PTGS2, SRC |
7.21493 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
7.21493 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, HSD17B2, IDO1, PTGS2, TYR, XDH |
7.21493 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, IDO1, PTGS2, SRC |
7.00188 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.99353 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, IDO1, NUAK1, PIM1, PTGS2, SMAD3, TOP2A, TYR, XDH |
6.56086 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
6.52191 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, IDO1, NUAK1, PIM1, PTGS2, SMAD3, TOP2A, TYR, XDH |
6.12717 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
6.09736 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
6.06184 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
6.0469 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.78358 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, IDO1, PTGS2, SRC, XDH |
5.64948 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
5.58301 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2, TYR |
5.48748 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
5.22844 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.76868 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.40645 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AOX1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
4.33124 |
[MF] GO:0005524 |
ATP binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
4.18883 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AOX1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
4.06804 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
4.06804 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AOX1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
4.06804 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
4.03759 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ABCB1, ADORA1, AOX1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
4.02963 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.00519 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.97735 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ADORA1, AOX1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TOP2A, XDH |
3.77355 |
[MF] GO:0043168 |
anion binding
|
ABCB1, AOX1, AURKB, AXL, CSNK2A1, DHFR, EGFR, F10, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
3.60867 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.55179 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, SMAD3 |
3.51024 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.42619 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, PIM1, SMAD3, SRC |
3.42619 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
3.28117 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
3.13212 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
3.02323 |
[MF] GO:0017076 |
purine nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.99729 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.99729 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.99729 |
[MF] GO:0032553 |
ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.99493 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, SMAD3, SRC |
2.91107 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB |
2.90276 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.90276 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, SMAD3, TEK |
2.88527 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, ADORA1, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.83144 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.79249 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.65909 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.65472 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, KDR, MET, PTGS2, SMAD3, TOP2A, TYR, XDH |
2.59852 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.54682 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.41221 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.37511 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.33557 |
[MF] GO:0019899 |
enzyme binding
|
AURKB, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRB, GSK3B, HSPA1A, MET, PTGS2, SMAD3, SRC, TEK, TOP2A |
2.326 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.26661 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.24491 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.24491 |
[MF] GO:0008013 |
beta-catenin binding
|
CSNK2A1, ESR1, GSK3B, SMAD3 |
2.23121 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, IGF1R, INSR |
2.18172 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB |
2.16707 |
[MF] GO:0035258 |
None
|
ESR1, FLT3, SMAD3, SRC |
2.13691 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.11342 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.11342 |